Additional file 1 of Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, first-in-human phase 1 study

Abstract

Additional file 1: Table S1. In vitro potency of crizotinib and conteltinib (CT-707). Table S2. Intracranial response of conteltinib (CT-707) in ALK-positive patients with brain metastasis